Recurrent Ovarian Germ Cell Tumor Completed Phase 1 Trials for Carboplatin (DB00958)

IndicationStatusPhase
DBCOND0029793 (Recurrent Ovarian Germ Cell Tumor)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00408655Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid TumorsTreatment
NCT01652794Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological CancerTreatment